253 related articles for article (PubMed ID: 8178328)
1. In vitro evaluation of platelet concentrates, prepared from pooled buffy coats, stored for 8 days after filtration.
Boomgaard MN; Joustra-Dijkhuis AM; Gouwerok CW; Steneker I; Reesink HW; Loos JA; Pietersz RN; de Korte D
Transfusion; 1994 Apr; 34(4):311-6. PubMed ID: 8178328
[TBL] [Abstract][Full Text] [Related]
2. Pooled platelet concentrates prepared by the platelet-rich-plasma method and filtered with three different filters and stored for 8 days.
Boomgaard MN; Gouwerok CW; Palfenier CH; Pankalla-Blandeau IE; Veldman HA; de Korte D; Loos JA
Vox Sang; 1995; 68(2):82-9. PubMed ID: 7762226
[TBL] [Abstract][Full Text] [Related]
3. Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma.
Boeri N; Saleun S; Pelissier E; Saleun JP; Aiach M; Rendu F
Transfusion; 1994 Oct; 34(10):881-6. PubMed ID: 7940660
[TBL] [Abstract][Full Text] [Related]
4. Storage of platelet concentrates from overnight-stored blood and overnight-stored buffy coat: in vitro studies.
Rácz Z; Baróti C
Vox Sang; 1995; 68(3):160-3. PubMed ID: 7625072
[TBL] [Abstract][Full Text] [Related]
5. Quality of pooled platelet concentrates prepared from buffy coats and stored in an additive solution after filtration.
Koerner K; Weihe R; Sahlmen P; Zeller B; Seifried E; Cardoso M; Kubanek B
Ann Hematol; 1995 Feb; 70(2):97-102. PubMed ID: 7880932
[TBL] [Abstract][Full Text] [Related]
6. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
[TBL] [Abstract][Full Text] [Related]
7. Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets.
Krailadsiri P; Seghatchian J
Vox Sang; 2000; 78(3):171-5. PubMed ID: 10838518
[TBL] [Abstract][Full Text] [Related]
8. Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage.
Lozano M; Estebanell E; Cid J; Diaz-Ricart M; Mazzara R; Ordinas A; Escolar G
Transfusion; 1999 Sep; 39(9):951-9. PubMed ID: 10533821
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new citrate-acetate-NaCl platelet additive solution for the storage of white cell-reduced platelet concentrates obtained from half-strength CPD pooled buffy coats.
van Rhenen DJ; Vermeij H; Kappers-Klunne M; Payrat JM
Transfusion; 1995 Jan; 35(1):50-3. PubMed ID: 7998070
[TBL] [Abstract][Full Text] [Related]
10. Preparation of leukodepleted platelet concentrates from pooled buffy coats: prestorage filtration with Autostop BC.
Pietersz RN; van der Meer PF; Steneker I; Hinloopen B; Dekker WJ; van Zanten AP; Reesink HW
Vox Sang; 1999; 76(4):231-6. PubMed ID: 10394143
[TBL] [Abstract][Full Text] [Related]
11. Platelet concentrates stored in synthetic medium after filtration.
Bertolini F; Rebulla P; Marangoni F; Sirchia G
Vox Sang; 1992; 62(2):82-6. PubMed ID: 1519372
[TBL] [Abstract][Full Text] [Related]
12. Platelet quality after 15-day storage of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Porretti L; Murphy S
Transfusion; 1992 Jan; 32(1):9-16. PubMed ID: 1731448
[TBL] [Abstract][Full Text] [Related]
13. Filtered platelet concentrates from pooled buffy coats show comparable storage lesions when stored for 9 d at 20-24 degrees C or when supplemented with thromboSol at 2-6 degrees C.
Schaller M; Hofmann A; Connor J; Nydegger UE
Eur J Haematol; 2000 Jun; 64(6):401-10. PubMed ID: 10901594
[TBL] [Abstract][Full Text] [Related]
14. Chemokines in stored platelet concentrates.
Bubel S; Wilhelm D; Entelmann M; Kirchner H; Klüter H
Transfusion; 1996 May; 36(5):445-9. PubMed ID: 8693510
[TBL] [Abstract][Full Text] [Related]
15. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates.
Wadhwa M; Krailadsiri P; Dilger P; Gaines Das R; Seghatchian MJ; Thorpe R
Vox Sang; 2002 Aug; 83(2):125-36. PubMed ID: 12201842
[TBL] [Abstract][Full Text] [Related]
16. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
Sandgren P; Hansson M; Gulliksson H; Shanwell A
Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
[TBL] [Abstract][Full Text] [Related]
17. Buffy coat platelets stored in apyrase, aprotinin, and ascorbic acid in a suspended bag: combined strategies for reducing platelet activation during storage.
Mrowiec ZR; Oleksowicz L; Zuckerman D; De Leon-Fernandez M; Khorshidi M; Dutcher JP; Puszkin EG
Transfusion; 1996 Jan; 36(1):5-10. PubMed ID: 8607153
[TBL] [Abstract][Full Text] [Related]
18. Storage of buffy coat preparations at 22 degrees C in plastic containers with different gas permeability.
Eriksson L; Eriksson G; Högman CF
Vox Sang; 1997; 73(2):74-80. PubMed ID: 9304775
[TBL] [Abstract][Full Text] [Related]
19. Effect of holding buffy coats 4 or 18 hours before preparing pooled filtered PLT concentrates in plasma.
Pérez-Pujol S; Lozano M; Perea D; Mazzara R; Ordinas A; Escolar G
Transfusion; 2004 Feb; 44(2):202-9. PubMed ID: 14962311
[TBL] [Abstract][Full Text] [Related]
20. [Determination of the cytokine level during storage of partially leukocyte-depleted (<0.5 x 10(9)) or totally leukocyte-depleted (<0.5 x 10(6)) platelets].
Algora M; Barbolla L; Zamora C; Moreno C; Rodríguez MA; Merino JL; Torres P
Sangre (Barc); 1997 Jun; 42(3):159-64. PubMed ID: 9381255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
